286 related articles for article (PubMed ID: 10473083)
1. Prognostic value of ornithine decarboxylase and polyamines in human breast cancer: correlation with clinicopathologic parameters.
Cañizares F; Salinas J; de las Heras M; Diaz J; Tovar I; Martinez P; Peñafiel R
Clin Cancer Res; 1999 Aug; 5(8):2035-41. PubMed ID: 10473083
[TBL] [Abstract][Full Text] [Related]
2. Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer.
Manni A; Mauger D; Gimotty P; Badger B
Clin Cancer Res; 1996 Nov; 2(11):1901-6. PubMed ID: 9816147
[TBL] [Abstract][Full Text] [Related]
3. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.
Weiss TS; Bernhardt G; Buschauer A; Thasler WE; Dolgner D; Zirngibl H; Jauch KW
Int J Colorectal Dis; 2002 Nov; 17(6):381-7. PubMed ID: 12355213
[TBL] [Abstract][Full Text] [Related]
4. Prognostic markers in node-negative breast cancer: a prospective study.
Kute TE; Russell GB; Zbieranski N; Long R; Johnston S; Williams H; Stackhouse C; Wilkins L; Evans I; Berry P; Rimmer K; Tucker E
Cytometry B Clin Cytom; 2004 May; 59(1):24-31. PubMed ID: 15108167
[TBL] [Abstract][Full Text] [Related]
5. Polyamine metabolism and recurrence after resection for hepatocellular carcinoma.
Kubo S; Tamori A; Tanaka H; Takemura S; Shuto T; Hirohashi K; Kinoshita H; Nishiguchi S
Hepatogastroenterology; 2004; 51(55):208-10. PubMed ID: 15011865
[TBL] [Abstract][Full Text] [Related]
6. Polyamines in human breast cancer and its relations to classical prognostic features: clinical implications.
Leveque J; Bansard JY; Watier E; Catros-Quemener V; Havouis R; Moulinoux JP; Grall JY; Seiler N
Anticancer Res; 1999; 19(3B):2275-9. PubMed ID: 10472343
[TBL] [Abstract][Full Text] [Related]
7. Relationship of ornithine decarboxylase activity and histological findings in human hepatocellular carcinoma.
Tamori A; Nishiguchi S; Kuroki T; Seki S; Kobayashi K; Kinoshita H; Otani S
Hepatology; 1994 Nov; 20(5):1179-86. PubMed ID: 7927250
[TBL] [Abstract][Full Text] [Related]
8. [Ornithine decarboxylase activity and polyamine levels in human thyroid tumor tissue].
Yamamoto O
Nihon Geka Gakkai Zasshi; 1989 Jul; 90(7):1049-56. PubMed ID: 2796972
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic features of breast cancer cells overexpressing ornithine-decarboxylase.
Manni A; Wechter R; Wei L; Heitjan D; Demers L
J Cell Physiol; 1995 Apr; 163(1):129-36. PubMed ID: 7896889
[TBL] [Abstract][Full Text] [Related]
11. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo.
Zhang B; Liu XX; Zhang Y; Jiang CY; Hu HY; Gong L; Liu M; Teng QS
J Gene Med; 2006 Aug; 8(8):980-9. PubMed ID: 16783835
[TBL] [Abstract][Full Text] [Related]
12. Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.
Hixson LJ; Emerson SS; Shassetz LR; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):317-23. PubMed ID: 8061580
[TBL] [Abstract][Full Text] [Related]
13. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer.
Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J
Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432
[TBL] [Abstract][Full Text] [Related]
14. Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.
Hixson LJ; Garewal HS; McGee DL; Sloan D; Fennerty MB; Sampliner RE; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):369-74. PubMed ID: 8348060
[TBL] [Abstract][Full Text] [Related]
15. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination.
Yu H; Levesque MA; Clark GM; Diamandis EP
Br J Cancer; 1999 Oct; 81(3):490-5. PubMed ID: 10507775
[TBL] [Abstract][Full Text] [Related]
16. Role of polyamines in estradiol-induced growth of human breast cancer cells.
Lima G; Shiu RP
Cancer Res; 1985 Jun; 45(6):2466-70. PubMed ID: 3921243
[TBL] [Abstract][Full Text] [Related]
17. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens.
Bettuzzi S; Davalli P; Astancolle S; Carani C; Madeo B; Tampieri A; Corti A
Cancer Res; 2000 Jan; 60(1):28-34. PubMed ID: 10646846
[TBL] [Abstract][Full Text] [Related]
18. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients.
Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M
Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of TGFbeta on proliferation of 7- and 14-day-old chick embryo fibroblasts and lack of involvement of the ODC/PA system in the TGFbeta signaling pathway.
Evangelisti R; Valeno V; Bosi G; Baroni T; Bellucci C; Carinci P
J Cell Physiol; 1999 Mar; 178(3):304-10. PubMed ID: 9989776
[TBL] [Abstract][Full Text] [Related]
20. Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry.
Ernestus RI; Röhn G; Schröder R; Els T; Klekner A ; Paschen W; Klug N
J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):88-92. PubMed ID: 11413269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
